Matthews, D R <br/><br/>
Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study.  [electronic resource] 

 -  Diabetes, obesity & metabolism  Sep 2010 
 - 780-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1463-1326 
<br/><br/><label>Standard No.: </label>10.1111/j.1463-1326.2010.01233.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adamantane--administration & dosage<br/>Adolescent<br/>Adult<br/>Aged<br/>Body Weight--drug effects<br/>Diabetes Mellitus, Type 2--blood<br/>Double-Blind Method<br/>Drug Therapy, Combination--methods<br/>Female<br/>Glycated Hemoglobin--metabolism<br/>Humans<br/>Hypoglycemia--chemically induced<br/>Hypoglycemic Agents--administration & dosage<br/>Male<br/>Metformin--administration & dosage<br/>Middle Aged<br/>Nitriles--administration & dosage<br/>Pyrrolidines--administration & dosage<br/>Sulfonylurea Compounds--administration & dosage<br/>Treatment Outcome<br/>Vildagliptin<br/>Weight Gain<br/>Young Adult